A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report

KISKAÇ, MUHARREM; ZORLU, MEHMET; ÇAKIRCA, MUSTAFA; KARATOPRAK, CUMALİ; Peru, Celalettin; Erkoc, Reha; Yavuz, Erdinc

doi:10.4103/0253-7613.111912

A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report

KISKAÇ M., ZORLU M., ÇAKIRCA M., KARATOPRAK C., Peru C., Erkoc R., ...Daha Fazla

INDIAN JOURNAL OF PHARMACOLOGY, cilt.45, sa.3, ss.305-306, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 45 Sayı: 3
Basım Tarihi: 2013
Doi Numarası: 10.4103/0253-7613.111912
Dergi Adı: INDIAN JOURNAL OF PHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.305-306
Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

Adverse effects due to use of fibrates often relate to the skeletal muscle, kidneys, or liver. Rhabdomyolysis is a most serious potential adverse effect. We present a case of resumed fenofibrate induced rhabdomyolysis complicated with acute renal failure.